Renaissance Technologies’s GSK GSK Stock Holding History

Renaissance Technologies’s Portfolio GSK Stock Details GSK Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$86.4M	Buy	2,250,853 +268,700	+14%	+$10.3M	0.12%	188
2025 Q1	$76.8M	Sell	1,982,153 -773,040	-28%	-$29.9M	0.12%	209
2024 Q4	$93.2M	Buy	2,755,193 +419,700	+18%	+$14.2M	0.14%	163
2024 Q3	$95.5M	Sell	2,335,493 -12,500	-0.5%	-$511K	0.14%	150
2024 Q2	$90.4M	Buy	2,347,993 +554,600	+31%	+$21.4M	0.15%	141
2024 Q1	$76.9M	Sell	1,793,393 -971,800	-35%	-$41.7M	0.12%	198
2023 Q4	$102M	Sell	2,765,193 -146,800	-5%	-$5.44M	0.16%	137
2023 Q3	$106M	Sell	2,911,993 -110,141	-4%	-$3.99M	0.18%	116
2023 Q2	$108M	Sell	3,022,134 -1,207,317	-29%	-$43M	0.16%	137
2023 Q1	$150M	Sell	4,229,451 -2,107,700	-33%	-$75M	0.2%	99
2022 Q4	$223M	Sell	6,337,151 -3,016,906	-32%	-$106M	0.3%	57
2022 Q3	$275M	Sell	9,354,057 -625,264	-6%	-$18.4M	0.39%	39
2022 Q2	$434M	Sell	9,979,321 -32,600	-0.3%	-$1.42M	0.51%	27
2022 Q1	$436M	Sell	10,011,921 -213,500	-2%	-$9.3M	0.51%	27
2021 Q4	$451M	Buy	10,225,421 +811,000	+9%	+$35.8M	0.56%	27
2021 Q3	$360M	Buy	9,414,421 +353,100	+4%	+$13.5M	0.46%	34
2021 Q2	$361M	Buy	9,061,321 +298,300	+3%	+$11.9M	0.45%	34
2021 Q1	$313M	Sell	8,763,021 -5,508,400	-39%	-$197M	0.39%	41
2020 Q4	$525M	Sell	14,271,421 -4,058,233	-22%	-$149M	0.57%	25
2020 Q3	$690M	Sell	18,329,654 -2,221,600	-11%	-$83.6M	0.69%	17
2020 Q2	$838M	Sell	20,551,254 -2,525,200	-11%	-$103M	0.72%	19
2020 Q1	$874M	Buy	23,076,454 +4,048,855	+21%	+$153M	0.85%	14
2019 Q4	$894M	Buy	19,027,599 +1,475,900	+8%	+$69.4M	0.69%	15
2019 Q3	$749M	Buy	17,551,699 +2,289,918	+15%	+$97.7M	0.63%	15
2019 Q2	$611M	Buy	15,261,781 +989,181	+7%	+$39.6M	0.54%	19
2019 Q1	$596M	Buy	14,272,600 +2,630,200	+23%	+$110M	0.54%	15
2018 Q4	$445M	Buy	11,642,400 +1,507,200	+15%	+$57.6M	0.49%	22
2018 Q3	$407M	Buy	10,135,200 +805,800	+9%	+$32.4M	0.42%	28
2018 Q2	$376M	Buy	9,329,400 +1,216,600	+15%	+$49M	0.41%	27
2018 Q1	$317M	Sell	8,112,800 -1,555,500	-16%	-$60.8M	0.35%	36
2017 Q4	$343M	Buy	9,668,300 +230,600	+2%	+$8.18M	0.38%	34
2017 Q3	$383M	Buy	9,437,700 +99,700	+1%	+$4.05M	0.45%	22
2017 Q2	$403M	Buy	9,338,000 +4,935,900	+112%	+$213M	0.51%	18
2017 Q1	$186M	Buy	4,402,100 +1,316,600	+43%	+$55.5M	0.26%	61
2016 Q4	$119M	Buy	3,085,500 +2,155,500	+232%	+$83M	0.19%	89
2016 Q3	$40.1M	Buy	930,000 +419,200	+82%	+$18.1M	0.07%	362
2016 Q2	$22.1M	Buy	510,800 +30,200	+6%	+$1.31M	0.04%	613
2016 Q1	$19.5M	Buy	480,600 +304,200	+172%	+$12.3M	0.04%	670
2015 Q4	$7.12M	Sell	176,400 -1,254,200	-88%	-$50.6M	0.02%	1227
2015 Q3	$55M	Sell	1,430,600 -1,815,500	-56%	-$69.8M	0.13%	140
2015 Q2	$135M	Buy	3,246,100 +633,500	+24%	+$26.4M	0.31%	39
2015 Q1	$121M	Sell	2,612,600 -3,394,200	-57%	-$157M	0.26%	56
2014 Q4	$257M	Sell	6,006,800 -820,800	-12%	-$35.1M	0.62%	13
2014 Q3	$314M	Sell	6,827,600 -2,041,800	-23%	-$93.9M	0.86%	9
2014 Q2	$474M	Buy	8,869,400 +1,859,600	+27%	+$99.5M	1.11%	9
2014 Q1	$375M	Buy	7,009,800 +584,800	+9%	+$31.2M	0.9%	10
2013 Q4	$343M	Buy	6,425,000 +2,533,700	+65%	+$135M	0.82%	9
2013 Q3	$195M	Buy	3,891,300 +2,533,800	+187%	+$127M	0.47%	28
2013 Q2	$67.8M	Buy	+1,357,500	New	+$67.8M	0.18%	114